Planned Study to Evaluate Finerenone + Semaglutide for Albuminuria in Non-Diabetic Obese CKD
Study on the Efficacy and Safety of Initial Combination of Finerenone and Semaglutide in Non-Diabetic Adult Patients With Obesity Complicated by Chronic Kidney Disease With Albuminuria
Abstract
A multicenter RCT will assess if finerenone combined with semaglutide further reduces albuminuria in non-diabetic obese patients with CKD over 24 weeks.
TitrateLab articles covering Semaglutide
Written by TitrateLab, separately from the study summarized above.
